SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
Clinical trial NCT05347134 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05347134
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-10
- Primary completion
- 2023-11-30
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.